Table 1.
Study participant details.
| Variable | Pilot site | Total value | ||
|
|
Athens | Freiburg |
|
|
| Participants, n | 14 | 5 | 19 | |
| Age (years), median (IQR) | 64.5 (15.5) | 72.0 (4.0) | 68.0 (11.0) | |
| Height (cm), median (IQR) | 157.5 (11.8) | 170.0 (2.0) | 160.0 (16.5) | |
| Weight (kg), median (IQR) | 67.0 (21.5) | 69.0 (8.0) | 69.0 (21.0) | |
| Male gender, % | 7.14 | 40.00 | 15.79 | |
| Mini-Balance Evaluation Systems Test score (rangea 0-28), median (IQR) | 21.5 (6.0) | 21.0 (1.0) | 21.0 (5.5) | |
| Functional Gait Assessment score (rangea 0-30), median (IQR) | 21.0 (5.0) | 22.0 (3.0) | 21.0 (5.5) | |
| Falls Efficacy Scale International score (rangea 16-64), median (IQR) | 27.5 (9.25) | 19.0 (8.0) | 27.0 (8.5) | |
| Montreal Cognitive Assessment score (rangea 0-30), median (IQR) | 25.5 (3.75) | 27.0 (4.0) | 26.0 (4.0) | |
| World Health Organization Disability Assessment Schedule score (rangea 100-0), median (IQR) | 23.0 (24.5) | 17.0 (21.0) | 17.0 (22.0) | |
| Activities-Specific Balance Confidence Scale score (rangea 0-100), median (IQR) | 76.9 (20.3) | 87.5 (15.0) | 82.5 (19.9) | |
aFor the score range a-b, “a” represents no disability and “b” represents the highest disability.